Details for Patent: 9,308,195
Which drugs does patent 9,308,195 protect, and when does it expire?
Patent 9,308,195 protects DOCETAXEL and is included in one NDA.
This patent has twenty-six patent family members in twenty-one countries.
Summary for Patent: 9,308,195
| Title: | Non-aqueous taxane formulations and methods of using the same |
| Abstract: | Non-aqueous, ethanol-free taxane formulations are provided. Formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the formulations, as well as kits that include the formulations. Non-aqueous, ethanol-free docetaxel formulations are provided. Formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the formulations, as well as kits that include the formulations. |
| Inventor(s): | Kiichiro Nabeta |
| Assignee: | Teikoku Pharma USA Inc |
| Application Number: | US14/564,384 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Device; |
Drugs Protected by US Patent 9,308,195
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-001 | Dec 22, 2015 | AP | RX | Yes | Yes | 9,308,195 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-002 | Dec 22, 2015 | AP | RX | Yes | Yes | 9,308,195 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-003 | Dec 22, 2015 | AP | RX | Yes | Yes | 9,308,195 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,308,195
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 092759 | ⤷ Start Trial | |||
| Australia | 2013327563 | ⤷ Start Trial | |||
| Brazil | 112015006692 | ⤷ Start Trial | |||
| Canada | 2885930 | ⤷ Start Trial | |||
| China | 104822262 | ⤷ Start Trial | |||
| China | 108464969 | ⤷ Start Trial | |||
| European Patent Office | 2903435 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
